Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which d… Read more
Diaceutics PLC (DIUXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.016x
Based on the latest financial reports, Diaceutics PLC (DIUXF) has a cash flow conversion efficiency ratio of 0.016x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($605.00K) by net assets ($37.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Diaceutics PLC - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Diaceutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Diaceutics PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diaceutics PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yi Jinn Industrial Co Ltd
TW:1457
|
0.004x |
|
PT Buma Internasional Grup Tbk
JK:DOID
|
-0.022x |
|
HKR International Limited
F:HKR
|
0.064x |
|
Midsona AB (publ)
ST:MSON-A
|
0.048x |
|
Jasuindo Tiga Perkasa Tbk
JK:JTPE
|
-0.046x |
|
Westag & Getalit AG
F:WUG3
|
0.015x |
|
Motonic
KO:009680
|
0.016x |
|
Asuransi Jiwa Sinarmas Msig PT
JK:LIFE
|
0.023x |
Annual Cash Flow Conversion Efficiency for Diaceutics PLC (2016–2024)
The table below shows the annual cash flow conversion efficiency of Diaceutics PLC from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $39.86 Million | $651.00K | 0.016x | -49.19% |
| 2023-12-31 | $40.79 Million | $1.31 Million | 0.032x | -73.45% |
| 2022-12-31 | $42.51 Million | $5.15 Million | 0.121x | +763.54% |
| 2021-12-31 | $40.65 Million | $570.00K | 0.014x | +123.02% |
| 2020-12-31 | $40.24 Million | $253.00K | 0.006x | +120.19% |
| 2019-12-31 | $20.13 Million | $-627.05K | -0.031x | +91.42% |
| 2018-12-31 | $2.63 Million | $-954.04K | -0.363x | -144.41% |
| 2017-12-31 | $1.88 Million | $1.53 Million | 0.817x | +22.70% |
| 2016-12-31 | $1.01 Million | $674.01K | 0.666x | -- |